Back
ARS Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50
SPRY
ARS Pharmaceuticals, Inc.
Last Price:
$11.50
Seasonality Move:
16.62%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SPRY is experiencing slight selling pressure.
ARS Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 10.53 | Buy |
| 20-day SMA: | 10.11 | Buy |
| 50-day SMA: | 9.37 | Buy |
| 200-day SMA: | 12.81 | Sell |
| 8-day EMA: | 7.67 | Buy |
| 20-day EMA: | 4.18 | Buy |
| 50-day EMA: | 1.92 | Buy |
| 200-day EMA: | 0.52 | Buy |
ARS Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.65 | Buy |
| Relative Strength Index (14 RSI): | 59.89 | Buy |
| Chaikin Money Flow: | -69507 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.28 - 10.82) | Buy |
| Bollinger Bands (100): | (8.29 - 13.27) | Buy |
ARS Pharmaceuticals, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for ARS Pharmaceuticals, Inc. Stock
Is ARS Pharmaceuticals, Inc. Stock a Buy?
-
ARS Pharmaceuticals, Inc. share price is 11.03 while SPRY 8-day simple moving average is 10.53, which is a Buy signal.
-
The stock price of SPRY is 11.03 while ARS Pharmaceuticals, Inc. 20-day SMA is 10.11, which makes it a Buy.
-
ARS Pharmaceuticals, Inc. 50-day simple moving average is 9.37 while SPRY share price is 11.03, making it a Buy technically.
-
SPRY stock price is 11.03 and ARS Pharmaceuticals, Inc. 200-day simple moving average is 12.81, creating a Sell signal.
SPRY Technical Analysis vs Fundamental Analysis
Sell
50
ARS Pharmaceuticals, Inc. (SPRY)
is a Sell
Is ARS Pharmaceuticals, Inc. a Buy or a Sell?
-
ARS Pharmaceuticals, Inc. stock is rated a SellThe current ARS Pharmaceuticals, Inc. [SPRY] share price is $11.03. The Score for SPRY is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
ARS Pharmaceuticals, Inc. Stock Info
Market Cap:
1.1B
Price in USD:
11.03
Share Volume:
1.3M
ARS Pharmaceuticals, Inc. 52-Week Range
52-Week High:
18.90
52-Week Low:
6.66
Sell
50
ARS Pharmaceuticals, Inc. (SPRY)
is a Sell
ARS Pharmaceuticals, Inc. Share Price Forecast
-
What is the ARS Pharmaceuticals, Inc. stock price today?The ARS Pharmaceuticals, Inc. stock price is 11.03 USD today.
-
Will SPRY stock go up or go down?ARS Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is ARS Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, ARS Pharmaceuticals, Inc. is overvalued.
Is ARS Pharmaceuticals, Inc. Stock a Buy?
-
ARS Pharmaceuticals, Inc. share price is 11.03 while SPRY 8-day exponential moving average is 7.67, which is a Buy signal.
-
The stock price of SPRY is 11.03 while ARS Pharmaceuticals, Inc. 20-day EMA is 4.18, which makes it a Buy.
-
ARS Pharmaceuticals, Inc. 50-day exponential moving average is 1.92 while SPRY share price is 11.03, making it a Buy technically.
-
SPRY stock price is 11.03 and ARS Pharmaceuticals, Inc. 200-day simple moving average is 0.52, creating a Buy signal.
Fundamental Analysis of ARS Pharmaceuticals, Inc.
Is ARS Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.22 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.24 per share, and an increase next year of $0.46 per share.
Technical Analysis of ARS Pharmaceuticals, Inc.
Should I short ARS Pharmaceuticals, Inc. stock?
-
SPRY Moving Average Covergence Divergence (MACD) indicator is 2.65, suggesting ARS Pharmaceuticals, Inc. is a Buy
-
ARS Pharmaceuticals, Inc. Relative Strength Index (RSI) is 59.89, which suggest ARS Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for ARS Pharmaceuticals, Inc. is (8.28 - 10.82), which suggest ARS Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for ARS Pharmaceuticals, Inc. is (8.29 - 13.27), which suggest ARS Pharmaceuticals, Inc. is a Buy
* ARS Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.